Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXJ9OM
|
||||
| Drug Name |
[3-Methyl-1-(3-oxo-tetrahydro-pyran-4-ylcarbamoyl)-butyl]-carbamic acid benzyl ester
|
||||
| Synonyms |
CHEMBL162631
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H26N2O5
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)NC2CCOCC2=O
|
||||
| InChI |
InChI=1S/C19H26N2O5/c1-13(2)10-16(18(23)20-15-8-9-25-12-17(15)22)21-19(24)26-11-14-6-4-3-5-7-14/h3-7,13,15-16H,8-12H2,1-2H3,(H,20,23)(H,21,24)/t15?,16-/m0/s1
|
||||
| InChIKey |
QURFFOZMRDDRRV-LYKKTTPLSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.